Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Neumora Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- +12 vs. Q3 2025
- Shares held
- 62.9M
- +12.3M (+24.3%) vs. Q3 2025
- Total value
- $112.7M
- +$20.5M (+22.3%) vs. Q3 2025
- New holders
- 24
- 33 more added
- Sold out
- 12
- 22 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 113 | $129.2M |
| Q1 2026 | 114 | $137.2M |
| Q4 2025 | 102 | $112.7M |
| Q3 2025 | 93 | $92.2M |
| Q2 2025 | 98 | $41.1M |
| Q1 2025 | 116 | $65.2M |
| Q4 2024 | 135 | $851.6M |
| Q3 2024 | 104 | $907.0M |
| Q2 2024 | 93 | $627.4M |
| Q1 2024 | 88 | $725.4M |
| Q4 2023 | 60 | $744.8M |
| Q3 2023 | 38 | $512.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Neumora Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Siren, L.L.C. | 6,288,783 | $11.3M | 0.34% | +1,930,500+44.3% | Added |
| Softbank Group Corp | 6,429,720 | $11.5M | 0.07% | −111,470−1.7% | Reduced |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,938,100−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −117,504−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −68,336−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −24,300−100.0% | Sold out |
| Brookstone Capital Management | 0 | $0 | 0.00% | −23,201−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −13,381−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −12,445−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,147−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −10,433−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,501−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −815−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |